share_log

Insider Sale: Chief Operating Officer of $JSPR (JSPR) Sells 900 Shares

Quiver Quantitative ·  Dec 13 09:16

Jeetinder Singh Mahal, the Chief Operating Officer of $JSPR ($JSPR), sold 900 shares of the company on 12-12-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.5% of their shares. Following this trade, they now own 25,009 shares of $JSPR stock.

$JSPR Insider Trading Activity

$JSPR insiders have traded $JSPR stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here's a breakdown of recent trading of $JSPR stock by insiders over the last 6 months:

  • JEETINDER SINGH MAHAL (Chief Operating Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 1,800 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$JSPR Hedge Fund Activity

We have seen 45 institutional investors add shares of $JSPR stock to their portfolio, and 44 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • AVIDITY PARTNERS MANAGEMENT LP removed 782,000 shares (-100.0%) from their portfolio in Q3 2024
  • BRAIDWELL LP added 483,300 shares (+inf%) to their portfolio in Q3 2024
  • INTEGRAL HEALTH ASSET MANAGEMENT, LLC added 350,000 shares (+inf%) to their portfolio in Q3 2024
  • OCTAGON CAPITAL ADVISORS LP removed 287,500 shares (-100.0%) from their portfolio in Q3 2024
  • SPHERA FUNDS MANAGEMENT LTD. removed 264,957 shares (-58.3%) from their portfolio in Q3 2024
  • MORGAN STANLEY added 256,303 shares (+82.8%) to their portfolio in Q3 2024
  • ALLY BRIDGE GROUP (NY) LLC added 180,852 shares (+82.7%) to their portfolio in Q3 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment